About Us

About Ossianix

Building on Strong Scientific Foundations

OSSIANIX is a privately held company with a proprietary brain shuttle platform allowing brain specific delivery of biotherapeutics across the Blood-Brain Barrier. The company headquarters are in the University City Science Center in downtown Philadelphia and have research laboratories at the Stevenage Bioscience Catalyst in Stevenage, Hertfordshire, UK. Ossianix was founded by Frank S. Walsh, Corey Goodman and J. Lynn Rutkowski who have had distinguished careers in Academia, Pharma and Biotech and bring a wealth of experience to the development of the next generation of Biologics. The company started operations in 2012 with funding from Lundbeck Pharmaceuticals, BioAdvance and the ALS Association.

Leadership Team

Following the Science

Frank S Walsh

CEO (Founder)

J Lynn Rutkowski

CSO (Founder)

Steve Moore

COO

Pawel Stocki

VP Research

Board of Directors

Experience and Skill

Mike J Owen

Chairman

Frank S Walsh

CEO

Share by: